Analysis of Serum Soluble Endoglin and s-CD105 Levels in Relation to Postoperative Recurrence and Metastasis in Breast Cancer Patients Treated with Modified Radical Mastectomy

This study demonstrates for the first time that postoperative serum sEC and s-CD105, measured at defined thresholds, independently predict recurrence/metastasis in breast cancer patients. Their combined assessment enhances prognostic accuracy beyond conventional staging, offering a novel tool for personalized surveillance and intervention strategies.